Delivery Order SPE2DB22D2103-SPE2DB24FR9CB

Award Date 3/22/24
Potential Completion Date 3/25/24
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $1,024.76 and a completion date of April 17, 2024. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a total potential value of up to $999,999,999.00 through December 31, 2025. The IDC enables...
The U.S. government agency Defense Logistics Agency (DLA) Troop Support Medical awarded a Firm Fixed Price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide M-M-R II vaccine vials. The contract, valued at $2,624.10, has an ultimate completion date of October 29, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary...
This is a $7,319.57 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for M-M-R II vaccine vials. The order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract, which runs through November...
This is a $26,643.76 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for the supply of M-M-R II vaccine vials. The contract has an ultimate completion date of July 19, 2024 and does not utilize a set-aside program. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for...
This is a $2,543.68 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II VACCINE VIALS. The delivery order is part of a larger Indefinite Delivery Contract (IDC) worth up to $999,999,999 with DLA Troop Support Medical for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. There is no set-aside designation for this...
The U.S. government agency, the Defense Logistics Agency (DLA), awarded a delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division. The $2,184.03 fixed-price contract is for the supply of M-M-R II vaccine vials. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities to support military treatment programs...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of M-M-R II vaccine vials. The contract has a ceiling value of $3,327.30 and a period of performance through April 30, 2025. The contract is not set aside and is an open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a $19,119.99 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of M-M-R II vaccine vials. The contract has a period of performance through July 18, 2024 and does not have a set-aside designation. Amerisourcebergen has been awarded numerous federal contracts and indefinite delivery vehicles (IDVs) by the DLA and other agencies to provide a wide range of pharmaceutical products...
The Defense Logistics Agency (DLA) awarded a $22,199.56 firm fixed price delivery order to Amerisourcebergen Drug Corp, a for-profit organization, for the supply of M-M-R II vaccine vials. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
The Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the delivery of M-M-R II vaccine vials. The contract has a ceiling value of $2,713.76 and a period of performance through March 29, 2024. This award is a task order under a larger indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp that has a potential value of $999,999,999.00 and runs...
  • SPE2DB22D2103
    Indefinite Delivery Contract
  • SPE2DB22D2103-SPE2DB24FR9CB
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a global pharmaceutical and medical supply distributor, to provide M-M-R II vaccine vials. The contract has a firm fixed price of $3,435.87 and a period of performance through March 25, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) with a potential value of $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for Amerisourcebergen to supply pharmaceuticals and medical materials to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this award.

Generated 6/21/24, 9:42 AM